[Federal Register Volume 75, Number 237 (Friday, December 10, 2010)]
[Notices]
[Page 76993]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-31066]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2010-N-0001]


Tobacco Products Scientific Advisory Committee; Notice of Meeting

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

    This notice announces a forthcoming meeting of a public advisory 
committee of the Food and Drug Administration (FDA). The meeting will 
be open to the public.

    Name of Committee: Tobacco Products Scientific Advisory 
Committee.
    General Function of the Committee: To provide advice and 
recommendations to the Agency on FDA's regulatory issues.
    Date and Time: The meeting will be held on January 10 and 11, 
2011 from 8 a.m. until 5 p.m.
    Location: FDA White Oak Conference Center, Bldg. 31, rm. 1503, 
10903 New Hampshire Ave., Silver Spring, MD 20993-0002. Information 
regarding special accommodations due to a disability, visitor 
parking and transportation may be accessed at: http://www.fda.gov/AdvisoryCommittees/default.htm; under the heading ``Resources for 
You,'' click on ``White Oak Conference Center Parking and 
Transportation Information for FDA Advisory Committee Meetings.'' 
Please note that visitors to the White Oak Campus must have a valid 
driver's license or other picture ID, and must enter through 
Building 1.
    Contact Person: Caryn Cohen, Office of Science, Center for 
Tobacco Products, Food and Drug Administration, 9200 Corporate 
Blvd., Rockville, MD 20850, 1-877-287-1373 (choose Option 4), e-
mail: <a href="/cdn-cgi/l/email-protection#c6929695878586a0a2a7e8aeaeb5e8a1a9b0"><span class="__cf_email__" data-cfemail="144044475557547270753a7c7c673a737b62">[email protected]</span></a>, or FDA Advisory Committee Information Line, 
1-800-741-8138 (301-443-0572 in the Washington, DC area), code 
8732110002. Please call the Information Line for up-to-date 
information on this meeting. A notice in the Federal Register about 
last minute modifications that impact a previously announced 
advisory committee meeting cannot always be published quickly enough 
to provide timely notice. Therefore, you should always check the 
Agency's Web site and call the appropriate advisory committee hot 
line/phone line to learn about possible modifications before coming 
to the meeting.
    Agenda: On January 10 and 11, 2011, the Committee will continue 
to (1) receive updates from the Menthol Report Subcommittee and (2) 
receive and discuss presentations regarding the data requested by 
the Committee at the March 30 and 31, 2010, meeting of the Tobacco 
Products Scientific Advisory Committee.
    FDA intends to make background material available to the public 
no later than 2 business days before the meeting. If FDA is unable 
to post the background material on its Web site prior to the 
meeting, the background material will be made publicly available at 
the location of the advisory committee meeting, and the background 
material will be posted on FDA's Web site after the meeting. 
Background material is available at http://www.fda.gov/AdvisoryCommittees/Calendar/default.htm. Scroll down to the 
appropriate advisory committee link.
    Procedure: Interested persons may present data, information, or 
views, orally or in writing, on issues pending before the committee. 
Written submissions may be made to the contact person on or before 
December 30, 2010. Oral presentations from the public will be 
scheduled between approximately 3 p.m. and 4 p.m. on January 10, 
2011. Those individuals interested in making formal oral 
presentations should notify the contact person and submit a brief 
statement of the general nature of the evidence or arguments they 
wish to present, the names and addresses of proposed participants, 
and an indication of the approximate time requested to make their 
presentation on or before December 21, 2010. Time allotted for each 
presentation may be limited. If the number of registrants requesting 
to speak is greater than can be reasonably accommodated during the 
scheduled open public hearing session, FDA may conduct a lottery to 
determine the speakers for the scheduled open public hearing 
session. The contact person will notify interested persons regarding 
their request to speak by December 22, 2010.
    Persons attending FDA's advisory committee meetings are advised 
that the Agency is not responsible for providing access to 
electrical outlets.
    FDA welcomes the attendance of the public at its advisory 
committee meetings and will make every effort to accommodate persons 
with physical disabilities or special needs. If you require special 
accommodations due to a disability, please contact Caryn Cohen at 
least 7 days in advance of the meeting.
    FDA is committed to the orderly conduct of its advisory 
committee meetings. Please visit our Web site at http://www.fda.gov/AdvisoryCommittees/AboutAdvisoryCommittees/ucm111462.htm for 
procedures on public conduct during advisory committee meetings.
    Notice of this meeting is given under the Federal Advisory 
Committee Act (5 U.S.C. app. 2).

    Dated: December 3, 2010.
Leslie Kux,
Acting Assistant Commissioner for Policy.
[FR Doc. 2010-31066 Filed 12-9-10; 8:45 am]
BILLING CODE 4160-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>